WCN25-1084 INTERNATIONAL RISK-PREDICTION TOOL IN IgAN AND THE PROGNOSTIC IMPLICATIONS OF CRESCENTS

WCN25-1084 INTERNATIONAL RISK-PREDICTION TOOL IN IgAN AND THE PROGNOSTIC IMPLICATIONS OF CRESCENTS

Saved in:

Bibliographic Details
Main Authors:	Beatriz Mendes, Ana Piedade, António Inácio, Francisca Fonseca, Karina Soto
Format:	Article
Language:	English
Published:	Elsevier 2025-02-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924023143
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

WCN25-4528 POST TRANSPLANT CRESCENTIC IgAN- FIRST CASE SERIES FROM INDIA
by: NITISH THAKUR, et al.
Published: (2025-02-01)

WCN25-799 EFFICACY AND SAFETY OF IPTACOPAN IN PATIENTS WITH IgA NEPHROPATHY (IgAN): INTERIM ANALYSIS (IA) OF THE PHASE 3 APPLAUSE-IgAN STUDY
by: Dmitrij Kollins, et al.
Published: (2025-02-01)

WCN25-1069 WHEN THE ANSWER IS IN THE URINARY SEDIMENT
by: Beatriz Mendes, et al.
Published: (2025-02-01)

WCN25-1585 A Phase 1/2 Trial of Zigakibart in IgA Nephropathy (IgAN)
by: Jonathan Barratt, et al.
Published: (2025-02-01)

WCN25-778 AFFINITY study: 1-year results of atrasentan in IgA nephropathy (IgAN)
by: Jonathan Barratt, et al.
Published: (2025-02-01)

WCN25-797 SAFETY AND EFFICACY OF IPTACOPAN IN PATIENTS WITH IgA NEPHROPATHY (IgAN) WITH BASELINE eGFR 20-<30 mL/MIN: PHASE 3 APPLAUSE-IgAN SUBCOHORT RESULTS
by: Dmitrij Kollins, et al.
Published: (2025-02-01)

WCN25-1884 SPARSENTAN (SPAR) AS FIRST-LINE TREATMENT OF INCIDENT PATIENTS WITH IgA NEPHROPATHY (IgAN): INTERIM ANALYSIS OF THE SPARTAN TRIAL
by: Chee Kay Cheung, et al.
Published: (2025-02-01)

WCN25-52 EPIDEMIOLOGY OF IMMUNOGLOBULIN A NEPHROPATHY (IgAN) AND OCCURRENCE OF PROTEINURIA IN CHINA: EVIDENCE FROM SYSTEMATIC REVIEW AND META-ANALYSIS
by: Zhaoxin Chen, et al.
Published: (2025-02-01)

WCN25-318 FELZARTAMAB DURABLY REDUCES DISEASE RELEVANT BIOMARKERS THROUGH TARGETING OF CD38+ PLASMA CELLS AND PLASMABLASTS, THE UPSTREAM DRIVERS OF IgA NEPHROPATHY (IgAN)
by: Lisa Kivman, et al.
Published: (2025-02-01)

WCN24-2308 WHAT TO EXPECT WHEN DIAGNOSING ANCA-ASSOCIATED VASCULITIS? A PORTUGUESE CENTER PERSPECTIVE AND EXPERIENCE
by: António Inácio, et al.
Published: (2024-04-01)

WCN24-1774 eGFR DECLINE IN PATIENTS WITH IgAN TREATED WITH NEFECON OR PLACEBO: RESULTS FROM THE 2-YEAR NefIgArd PHASE 3 TRIAL
by: Richard Lafayette, et al.
Published: (2024-04-01)

Crescents proportions above 10% are associated with unfavorable kidney outcomes in IgA nephropathy patients with partial crescent formation
by: Dingxin Di, et al.
Published: (2023-12-01)

Durvalumab-Associated Crescentic Glomerulonephritis With IgA Vasculitis-Like Features
by: Tao Zhao, et al.
Published: (2025-07-01)

WCN24-1777 NEFECON TREATMENT PROVIDES KIDNEY BENEFITS FOR PATIENTS WITH IgAN THAT EXTEND TO THOSE WITH LOW LEVELS OF UPCR: A SUB-ANALYSIS OF THE PHASE III NefIgArd TRIAL
by: Jonathan Barratt, et al.
Published: (2024-04-01)

Burden of corticosteroid therapy in patients with immunoglobulin A nephropathy (IgAN): a systematic literature review
by: Sarah N. Ali, et al.
Published: (2025-05-01)

WCN24-283 CAN SERUM AND HISTOLOGIC BIOMARKERS PREDICT KIDNEY AND OVERALL SURVIVAL IN ANCA-ASSOCIATED VASCULITIS?
by: António Inácio, et al.
Published: (2024-04-01)

WCN24-577 STEROID CONTROVERSIES IN THE TREATMENT OF IGANEPHROPATHY: CLINICAL CASE OF RAPID PROGRESSIVE IGAN
by: Olga Chub
Published: (2024-04-01)

2bRAD-M reveals circulating microbiome in chronic antibody-mediated rejection (CAMR) and IgA nephropathy (IgAN) after kidney transplantation
by: Yan-Xin Tao, et al.
Published: (2025-07-01)

WCN25-1128 IgA DOMINANT INFECTION RELATED GLOMERULONEPHRITIS
by: Fatima Alkindi, et al.
Published: (2025-02-01)

WCN25-2494 SURPRISINGLY GOOD RESPONSE OF A SEVERE ANCA-NEGATIVE CRESCENTIC PAUCI-IMMUNE GLOMERULONEPHRITIS SUCCESSFULLY TREATED WITH CORTICOSTEROIDS, CYCLOPHOSPHAMIDE AND RITUXIMAB
by: Eleni Theodoropoulou, et al.
Published: (2025-02-01)

Euglycemic Ketoacidosis in a non-diabetic patient: a rare adverse effect of sodium-glucose co-transporter type-2 inhibitors. A review based on a case report
by: Francisca Fonseca, et al.
Published: (2025-01-01)

IgA nephropathy with crescent cell lesions in a human brucellosis patient: a case report
by: Dongli Qi, et al.
Published: (2025-08-01)

WCN25-1471 IgA Nephropathy with Anti-Neutrophil Cytoplasmic Antibodies in a Middle-Aged Patient
by: Giovanna Yazmin Arteaga Müller, et al.
Published: (2025-02-01)

WCN25-1709 Salivary and Urinary Metabolomics Study in IgA Nephropathy Patients
by: Rümeyza Kazancıoğlu, et al.
Published: (2025-02-01)

Clinicopathological features of IgA nephropathy in children and adults assessed by the Oxford classification and glomerular crescent lesion typing
by: Bai Qiu-yu, et al.
Published: (2025-03-01)

Phaon Crescent, Mat Plant Crescent, Physiodes phaon (Edwards) (Insecta: Lepidoptera: Nymphalidae)
by: Donald W. Hall, et al.
Published: (2002-11-01)

The Evolution of Crescents in Lupus Nephritis
by: Ana Malvar, et al.
Published: (2025-05-01)

Mass balance of IGAN Glacier (the Polar Urals) in 2018–2023
by: G. A. Nosenko, et al.
Published: (2025-02-01)

WCN25-2007 Evaluation of treatment strategy in patients with IgA nephropathy with impaired renal function
by: Ryousuke Aoki, et al.
Published: (2025-02-01)

WCN25-2573 CHARACTERISTICS OF IgG4 RELATED RENAL DISEASE IN KIDNEY BIOPSY – CASE SERIES
by: Malathi CV, et al.
Published: (2025-02-01)

Cetuximab-Associated Crescentic Diffuse Proliferative Glomerulonephritis
by: Sukesh Manthri, et al.
Published: (2017-01-01)

WCN24-2099 BASELINE CHARACTERISTICS OF THE ALIGN TRIAL: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL OF ATRASENTAN IN PATIENTS WITH IGAN
by: Hiddo J.L. Heerspink, et al.
Published: (2024-04-01)

WCN24-2046 COMPARATIVE ANALYSIS OF INTERNATIONAL IGAN PREDICTION TOOL SCORES DURING TIME OF BIOPSY AND ONE-YEAR POSTBIOPSY IN PREDICTING RENAL OUTCOMES AMONG FILIPINO PATIENTS WITH IGA NEPHROPATHY
by: JANJOEL SIMPAUCO, et al.
Published: (2024-04-01)

WCN25-4090 The Diagnostic potential of Serum Gd-IgA1 to C3 ratio in IgA nephropathy: A single center prospective study
by: Ravi tej Madipalli, et al.
Published: (2025-02-01)

Remodelação de costelas: Popularidade crescente, evidências escassas
by: Julia Leite Munhoz, et al.
Published: (2024-12-01)

Mastopexia crescente com implantes de silicone: um estudo longitudinal prospectivo Crescent mastopexy with silicone implants: a longitudinal prospective study
by: Denis Souto Valente, et al.
Published: (2012-12-01)

WCN25-4466 Baseline parameters of IgA Nephropathy Using the Oxford MEST Score: Insights from the I-TANGIBLE Registry
by: Kavita Yadav, et al.
Published: (2025-02-01)

WCN25-1039 Prognostic Impact of Malnutrition Risk in Patients with Sepsis-Induced Acute Kidney Injury
by: Pham Dang Hai, et al.
Published: (2025-02-01)

Testing Mesoamerican Lunate Artifacts as Possible Crescent Loom Weights
by: Billie J. A. Follensbee
Published: (2020-11-01)

Recurrent Crescentic Infection Related Glomerulonephritis: a rare presentation
by: Kapil Naveen Sejpal, et al.
Published: (2022-01-01)